GeoVax Labs Total Assets Growth & History (GOVX)
GeoVax Labs's total assets was $6.3M for fiscal 2025.
View full GeoVax Labs company overviewGeoVax Labs annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.3M | −$1.8M | −22.24% |
| 2024 | 2024-12-31 | $8.2M | −$1.1M | −12.14% |
| 2023 | 2023-12-31 | $9.3M | −$22.1M | −70.39% |
| 2022 | 2022-12-31 | $31.3M | $19.6M | +165.73% |
| 2021 | 2021-12-31 | $11.8M | $1.4M | +13.50% |
| 2020 | 2020-12-31 | $10.4M | $9.9M | +2116.75% |
| 2019 | 2019-12-31 | $468,880 | −$173,184 | −26.97% |
| 2018 | 2018-12-31 | $642,064 | $151,829 | +30.97% |
| 2017 | 2017-12-31 | $490,235 | −$119,982 | −19.66% |
| 2016 | 2016-12-31 | $610,217 | −$721,376 | −54.17% |
| 2015 | 2015-12-31 | $1.3M | −$1,605 | −0.12% |
| 2014 | 2014-12-31 | $1.3M | −$1.5M | −53.05% |
| 2013 | 2013-12-31 | $2.8M | $1.4M | +92.13% |
| 2012 | 2012-12-31 | $1.5M | −$167,172 | −10.16% |
| 2011 | 2011-12-31 | $1.6M | −$712,692 | −30.23% |
| 2010 | 2010-12-31 | $2.4M | — | — |
GeoVax Labs quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.6M | −$707,663 | −13.23% |
| Q1 2026 | 2026-03-31 | $3.0M | −$7.9M | −72.47% |
| Q4 2025 | 2025-12-31 | $6.3M | −$1.8M | −22.24% |
| Q3 2025 | 2025-09-30 | $6.7M | −$4.4M | −39.42% |
| Q2 2025 | 2025-06-30 | $5.4M | $1.3M | +30.66% |
| Q1 2025 | 2025-03-31 | $10.8M | $7.5M | +222.60% |
| Q4 2024 | 2024-12-31 | $8.2M | −$1.1M | −12.14% |
| Q3 2024 | 2024-09-30 | $11.1M | −$5.1M | −31.41% |
| Q2 2024 | 2024-06-30 | $4.1M | −$17.2M | −80.73% |
| Q1 2024 | 2024-03-31 | $3.4M | −$24.0M | −87.75% |
| Q4 2023 | 2023-12-31 | $9.3M | −$22.1M | −70.39% |
| Q3 2023 | 2023-09-30 | $16.2M | −$22.4M | −58.00% |
| Q2 2023 | 2023-06-30 | $21.2M | −$12.0M | −36.07% |
| Q1 2023 | 2023-03-31 | $27.4M | $10.5M | +62.59% |
| Q4 2022 | 2022-12-31 | $31.3M | $19.6M | +165.73% |
| Q3 2022 | 2022-09-30 | $38.6M | $20.2M | +110.31% |
| Q2 2022 | 2022-06-30 | $33.2M | $13.4M | +67.73% |
| Q1 2022 | 2022-03-31 | $16.9M | −$4.3M | −20.18% |
| Q4 2021 | 2021-12-31 | $11.8M | $1.4M | +13.50% |
| Q3 2021 | 2021-09-30 | $18.3M | $6.6M | +56.00% |
| Q2 2021 | 2021-06-30 | $19.8M | $18.9M | +1968.74% |
| Q1 2021 | 2021-03-31 | $21.1M | $20.3M | +2441.48% |
| Q4 2020 | 2020-12-31 | $10.4M | $9.9M | +2116.75% |
| Q3 2020 | 2020-09-30 | $11.8M | $10.9M | +1339.74% |
| Q2 2020 | 2020-06-30 | $957,943 | $615,310 | +179.58% |
| Q1 2020 | 2020-03-31 | $830,833 | $358,189 | +75.78% |
| Q4 2019 | 2019-12-31 | $468,880 | −$173,184 | −26.97% |
| Q3 2019 | 2019-09-30 | $816,529 | $193,062 | +30.97% |
| Q2 2019 | 2019-06-30 | $342,633 | −$28,747 | −7.74% |
| Q1 2019 | 2019-03-31 | $472,644 | −$366,861 | −43.70% |
| Q4 2018 | 2018-12-31 | $642,064 | $151,829 | +30.97% |
| Q3 2018 | 2018-09-30 | $623,467 | $127,832 | +25.79% |
| Q2 2018 | 2018-06-30 | $371,380 | −$618,629 | −62.49% |
| Q1 2018 | 2018-03-31 | $839,505 | $535,828 | +176.45% |
| Q4 2017 | 2017-12-31 | $490,235 | −$119,982 | −19.66% |
| Q3 2017 | 2017-09-30 | $495,635 | −$179,556 | −26.59% |
| Q2 2017 | 2017-06-30 | $990,009 | $650,956 | +191.99% |
| Q1 2017 | 2017-03-31 | $303,677 | −$492,775 | −61.87% |
| Q4 2016 | 2016-12-31 | $610,217 | −$721,376 | −54.17% |
| Q3 2016 | 2016-09-30 | $675,191 | −$1.3M | −66.21% |
| Q2 2016 | 2016-06-30 | $339,053 | −$2.3M | −87.27% |
| Q1 2016 | 2016-03-31 | $796,452 | −$2.6M | −76.29% |
| Q4 2015 | 2015-12-31 | $1.3M | −$1,605 | −0.12% |
| Q3 2015 | 2015-09-30 | $2.0M | $945,037 | +89.74% |
| Q2 2015 | 2015-06-30 | $2.7M | $1.1M | +75.19% |
| Q1 2015 | 2015-03-31 | $3.4M | $1.2M | +54.59% |
| Q4 2014 | 2014-12-31 | $1.3M | −$1.5M | −53.05% |
| Q3 2014 | 2014-09-30 | $1.1M | −$908,210 | −46.31% |
| Q2 2014 | 2014-06-30 | $1.5M | −$523,601 | −25.61% |
| Q1 2014 | 2014-03-31 | $2.2M | $43,214 | +2.03% |
| Q4 2013 | 2013-12-31 | $2.8M | $1.4M | +92.13% |
| Q3 2013 | 2013-09-30 | $2.0M | −$74,835 | −3.68% |
| Q2 2013 | 2013-06-30 | $2.0M | −$246,067 | −10.74% |
| Q1 2013 | 2013-03-31 | $2.1M | −$707,516 | −24.94% |
| Q4 2012 | 2012-12-31 | $1.5M | −$167,172 | −10.16% |
| Q3 2012 | 2012-09-30 | $2.0M | $223,618 | +12.34% |
| Q2 2012 | 2012-06-30 | $2.3M | $155,912 | +7.30% |
| Q1 2012 | 2012-03-31 | $2.8M | — | — |
| Q4 2011 | 2011-12-31 | $1.6M | −$712,692 | −30.23% |
| Q3 2011 | 2011-09-30 | $1.8M | — | — |
| Q2 2011 | 2011-06-30 | $2.1M | — | — |
| Q4 2010 | 2010-12-31 | $2.4M | — | — |
GeoVax Labs total assets trends
Over the last five fiscal years, GeoVax Labs's total assets decreased from $10.4M to $6.3M, a change of −$4.1M. The latest reported quarter, Q2 2026, shows $4.6M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GeoVax Labs source filings ↗